TEPNEL PHARMA SERVICES LIMITEDActive

Company number SC635641Private limited companyIncorporated 2019

Key figures

£973,546+7.0%
Net assets 2025
+24.9%
Average annual growth 2020–2025
0500 k1 m1.5 m2020202320242025

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2020202320242025
Filed accounts2020–2025
2020202320242025
Turnover2,295,7683,150,6073,422,6983,391,224
Profit for the year498,977223,736211,487248,102
Cash at bank and in hand933,036622,509655,648835,177
Total assets1,556,2751,611,1361,591,4971,556,346
Total liabilities1,057,153558,228657,617563,182
Net assets / total equity499,1221,032,270910,157973,546
Average number of employees32323130

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company is the provision of quality control testing of developmental and market authorised biopharmaceuticals in support of global drug development with an emphasis on improving patient outcomes.

As described in the company's latest filed accounts.

Summary: TEPNEL PHARMA SERVICES LIMITED

Company

TEPNEL PHARMA SERVICES LIMITED is a private limited company registered with Companies House under company number SC635641. It was incorporated on 9 Jul 2019. Its status is active. The registered office is in Glasgow (G2). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Turnover was £3,391,224. Profit for the year was £248,102. Net assets were £973,546, up 7% on the previous year. Cash at bank and in hand was £835,177. Total assets were £1,556,346 and total liabilities £563,182. The company had an average of 30 employees. Figures are available for 4 financial years (2020–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 22 Jul 2027.